Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis

Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2024-05, Vol.59 (9), p.1049-1061
Hauptverfasser: Ramirez‐Cadiz, Carolina, Blaney, Hanna, Kubanek, Natalia, Díaz, Luis Antonio, Loomba, Rohit, Skladany, Lubomir, Arab, Juan Pablo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1061
container_issue 9
container_start_page 1049
container_title Alimentary pharmacology & therapeutics
container_volume 59
creator Ramirez‐Cadiz, Carolina
Blaney, Hanna
Kubanek, Natalia
Díaz, Luis Antonio
Loomba, Rohit
Skladany, Lubomir
Arab, Juan Pablo
description Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate. Aims To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH. Methods We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’ Results Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use. Conclusions While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.
doi_str_mv 10.1111/apt.17948
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2956687255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3034668289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3488-7b77244f8b5ee1e6277ac5df4be80f0ac22a3f036b9e1dc9c8e7dd0cddd108d13</originalsourceid><addsrcrecordid>eNp1kc9KHTEUh4O06O21C19AAt3YxWj-zEwy3cmltoKgiF2HTHIGI7mTaZJR7k7oC_iMfZJGr3ZRaDaHkO98nJwfQgeUHNNyTvSUj6noarmDFpS3TcUIb9-hBWFtVzFJ-R76kNIdIaQVhO2iPS5r0ciOL9Cva7h38IB1zM54-IJXc4wwZuxG64zOLowJ69HiBB7M8xWb6DJEp_EQIgYd_QZ7dw8R56jHNHk95pe-oihd5QGw9ibcBv_78UmnFIzTGSy-halw2aV99H7QPsHH17pEP86-3qy-VxeX385XpxeV4bWUleiFYHU9yL4BoNAyIbRp7FD3IMlAtGFM86H8vO-AWtMZCcJaYqy1lEhL-RIdbb1TDD9nSFmtXTLgy8QQ5qRY17StFKxpCvrpH_QuzHEs0ylOeF0wVta3RJ-3lIkhpQiDmqJb67hRlKjnZFRJRr0kU9jDV-Pcr8H-Jd-iKMDJFnhwHjb_N6nTq5ut8g98kJxq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3034668289</pqid></control><display><type>article</type><title>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Ramirez‐Cadiz, Carolina ; Blaney, Hanna ; Kubanek, Natalia ; Díaz, Luis Antonio ; Loomba, Rohit ; Skladany, Lubomir ; Arab, Juan Pablo</creator><creatorcontrib>Ramirez‐Cadiz, Carolina ; Blaney, Hanna ; Kubanek, Natalia ; Díaz, Luis Antonio ; Loomba, Rohit ; Skladany, Lubomir ; Arab, Juan Pablo</creatorcontrib><description>Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate. Aims To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH. Methods We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’ Results Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use. Conclusions While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.</description><identifier>ISSN: 0269-2813</identifier><identifier>ISSN: 1365-2036</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.17948</identifier><identifier>PMID: 38475893</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Abstinence ; alcohol ; Alcohol use ; alcohol use disorders ; alcoholic hepatitis ; alcoholic liver disease ; Alcoholism - complications ; alcohol‐associated hepatitis ; cirrhosis ; Hepatitis ; Hepatitis, Alcoholic - complications ; Hepatitis, Alcoholic - diagnosis ; Hepatitis, Alcoholic - surgery ; Humans ; Inflammation ; Liver diseases ; Liver Diseases, Alcoholic - complications ; Liver transplantation ; Liver Transplantation - adverse effects ; Liver transplants ; Patient Selection ; Survival</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2024-05, Vol.59 (9), p.1049-1061</ispartof><rights>2024 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2024 The Authors. Alimentary Pharmacology &amp; Therapeutics published by John Wiley &amp; Sons Ltd.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3488-7b77244f8b5ee1e6277ac5df4be80f0ac22a3f036b9e1dc9c8e7dd0cddd108d13</cites><orcidid>0000-0002-4845-9991 ; 0000-0003-4919-9519 ; 0000-0002-8561-396X ; 0000-0001-9905-7741 ; 0000-0002-6805-0560 ; 0000-0002-8540-4930 ; 0000-0001-5171-3623</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.17948$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.17948$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38475893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramirez‐Cadiz, Carolina</creatorcontrib><creatorcontrib>Blaney, Hanna</creatorcontrib><creatorcontrib>Kubanek, Natalia</creatorcontrib><creatorcontrib>Díaz, Luis Antonio</creatorcontrib><creatorcontrib>Loomba, Rohit</creatorcontrib><creatorcontrib>Skladany, Lubomir</creatorcontrib><creatorcontrib>Arab, Juan Pablo</creatorcontrib><title>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate. Aims To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH. Methods We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’ Results Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use. Conclusions While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.</description><subject>Abstinence</subject><subject>alcohol</subject><subject>Alcohol use</subject><subject>alcohol use disorders</subject><subject>alcoholic hepatitis</subject><subject>alcoholic liver disease</subject><subject>Alcoholism - complications</subject><subject>alcohol‐associated hepatitis</subject><subject>cirrhosis</subject><subject>Hepatitis</subject><subject>Hepatitis, Alcoholic - complications</subject><subject>Hepatitis, Alcoholic - diagnosis</subject><subject>Hepatitis, Alcoholic - surgery</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Liver diseases</subject><subject>Liver Diseases, Alcoholic - complications</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - adverse effects</subject><subject>Liver transplants</subject><subject>Patient Selection</subject><subject>Survival</subject><issn>0269-2813</issn><issn>1365-2036</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc9KHTEUh4O06O21C19AAt3YxWj-zEwy3cmltoKgiF2HTHIGI7mTaZJR7k7oC_iMfZJGr3ZRaDaHkO98nJwfQgeUHNNyTvSUj6noarmDFpS3TcUIb9-hBWFtVzFJ-R76kNIdIaQVhO2iPS5r0ciOL9Cva7h38IB1zM54-IJXc4wwZuxG64zOLowJ69HiBB7M8xWb6DJEp_EQIgYd_QZ7dw8R56jHNHk95pe-oihd5QGw9ibcBv_78UmnFIzTGSy-halw2aV99H7QPsHH17pEP86-3qy-VxeX385XpxeV4bWUleiFYHU9yL4BoNAyIbRp7FD3IMlAtGFM86H8vO-AWtMZCcJaYqy1lEhL-RIdbb1TDD9nSFmtXTLgy8QQ5qRY17StFKxpCvrpH_QuzHEs0ylOeF0wVta3RJ-3lIkhpQiDmqJb67hRlKjnZFRJRr0kU9jDV-Pcr8H-Jd-iKMDJFnhwHjb_N6nTq5ut8g98kJxq</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Ramirez‐Cadiz, Carolina</creator><creator>Blaney, Hanna</creator><creator>Kubanek, Natalia</creator><creator>Díaz, Luis Antonio</creator><creator>Loomba, Rohit</creator><creator>Skladany, Lubomir</creator><creator>Arab, Juan Pablo</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4845-9991</orcidid><orcidid>https://orcid.org/0000-0003-4919-9519</orcidid><orcidid>https://orcid.org/0000-0002-8561-396X</orcidid><orcidid>https://orcid.org/0000-0001-9905-7741</orcidid><orcidid>https://orcid.org/0000-0002-6805-0560</orcidid><orcidid>https://orcid.org/0000-0002-8540-4930</orcidid><orcidid>https://orcid.org/0000-0001-5171-3623</orcidid></search><sort><creationdate>202405</creationdate><title>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</title><author>Ramirez‐Cadiz, Carolina ; Blaney, Hanna ; Kubanek, Natalia ; Díaz, Luis Antonio ; Loomba, Rohit ; Skladany, Lubomir ; Arab, Juan Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3488-7b77244f8b5ee1e6277ac5df4be80f0ac22a3f036b9e1dc9c8e7dd0cddd108d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abstinence</topic><topic>alcohol</topic><topic>Alcohol use</topic><topic>alcohol use disorders</topic><topic>alcoholic hepatitis</topic><topic>alcoholic liver disease</topic><topic>Alcoholism - complications</topic><topic>alcohol‐associated hepatitis</topic><topic>cirrhosis</topic><topic>Hepatitis</topic><topic>Hepatitis, Alcoholic - complications</topic><topic>Hepatitis, Alcoholic - diagnosis</topic><topic>Hepatitis, Alcoholic - surgery</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Liver diseases</topic><topic>Liver Diseases, Alcoholic - complications</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - adverse effects</topic><topic>Liver transplants</topic><topic>Patient Selection</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramirez‐Cadiz, Carolina</creatorcontrib><creatorcontrib>Blaney, Hanna</creatorcontrib><creatorcontrib>Kubanek, Natalia</creatorcontrib><creatorcontrib>Díaz, Luis Antonio</creatorcontrib><creatorcontrib>Loomba, Rohit</creatorcontrib><creatorcontrib>Skladany, Lubomir</creatorcontrib><creatorcontrib>Arab, Juan Pablo</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramirez‐Cadiz, Carolina</au><au>Blaney, Hanna</au><au>Kubanek, Natalia</au><au>Díaz, Luis Antonio</au><au>Loomba, Rohit</au><au>Skladany, Lubomir</au><au>Arab, Juan Pablo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2024-05</date><risdate>2024</risdate><volume>59</volume><issue>9</issue><spage>1049</spage><epage>1061</epage><pages>1049-1061</pages><issn>0269-2813</issn><issn>1365-2036</issn><eissn>1365-2036</eissn><abstract>Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate. Aims To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH. Methods We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’ Results Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use. Conclusions While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38475893</pmid><doi>10.1111/apt.17948</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-4845-9991</orcidid><orcidid>https://orcid.org/0000-0003-4919-9519</orcidid><orcidid>https://orcid.org/0000-0002-8561-396X</orcidid><orcidid>https://orcid.org/0000-0001-9905-7741</orcidid><orcidid>https://orcid.org/0000-0002-6805-0560</orcidid><orcidid>https://orcid.org/0000-0002-8540-4930</orcidid><orcidid>https://orcid.org/0000-0001-5171-3623</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2024-05, Vol.59 (9), p.1049-1061
issn 0269-2813
1365-2036
1365-2036
language eng
recordid cdi_proquest_miscellaneous_2956687255
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals
subjects Abstinence
alcohol
Alcohol use
alcohol use disorders
alcoholic hepatitis
alcoholic liver disease
Alcoholism - complications
alcohol‐associated hepatitis
cirrhosis
Hepatitis
Hepatitis, Alcoholic - complications
Hepatitis, Alcoholic - diagnosis
Hepatitis, Alcoholic - surgery
Humans
Inflammation
Liver diseases
Liver Diseases, Alcoholic - complications
Liver transplantation
Liver Transplantation - adverse effects
Liver transplants
Patient Selection
Survival
title Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A18%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20article:%20Current%20indications%20and%20selection%20criteria%20for%20early%20liver%20transplantation%20in%20severe%20alcohol%E2%80%90associated%20hepatitis&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Ramirez%E2%80%90Cadiz,%20Carolina&rft.date=2024-05&rft.volume=59&rft.issue=9&rft.spage=1049&rft.epage=1061&rft.pages=1049-1061&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.17948&rft_dat=%3Cproquest_cross%3E3034668289%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3034668289&rft_id=info:pmid/38475893&rfr_iscdi=true